Jun 24 |
GSK's Filing for Expanded Use of Jemperli Gets EMA Acceptance
|
Jun 19 |
Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold
|
Jun 18 |
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
|
Jun 5 |
Aligos Therapeutics Presents Positive Data at the EASL Congress 2024
|
Jun 4 |
Here's Why Aligos Therapeutics (ALGS) Is a Great 'Buy the Bottom' Stock Now
|
May 22 |
Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
|
May 16 |
After Plunging -13.71% in 4 Weeks, Here's Why the Trend Might Reverse for Aligos Therapeutics (ALGS)
|
May 9 |
Aligos Therapeutics First Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.54 loss in 1Q 2023)
|
May 8 |
Aligos Therapeutics reports Q1 results
|
May 7 |
Aligos Therapeutics Reports Recent Business Progress andĀ First Quarter 2024 Financial Results
|